Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells.

Haney MJ, Zhao Y, Li S, Higginbotham SM, Booth SL, Han HY, Vetro JA, Mosley RL, Kabanov AV, Gendelman HE, Batrakova EV.

Nanomedicine (Lond). 2011 Sep;6(7):1215-30. doi: 10.2217/nnm.11.32. Epub 2011 Mar 31.

PMID:
21449849
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery.

Haney MJ, Suresh P, Zhao Y, Kanmogne GD, Kadiu I, Sokolsky-Papkov M, Klyachko NL, Mosley RL, Kabanov AV, Gendelman HE, Batrakova EV.

Nanomedicine (Lond). 2012 Jun;7(6):815-33. doi: 10.2217/nnm.11.156. Epub 2012 Jan 11.

PMID:
22236307
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease.

Brynskikh AM, Zhao Y, Mosley RL, Li S, Boska MD, Klyachko NL, Kabanov AV, Gendelman HE, Batrakova EV.

Nanomedicine (Lond). 2010 Apr;5(3):379-96. doi: 10.2217/nnm.10.7.

PMID:
20394532
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles.

Zhao Y, Haney MJ, Klyachko NL, Li S, Booth SL, Higginbotham SM, Jones J, Zimmerman MC, Mosley RL, Kabanov AV, Gendelman HE, Batrakova EV.

Nanomedicine (Lond). 2011 Jan;6(1):25-42. doi: 10.2217/nnm.10.129.

PMID:
21182416
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A macrophage-nanozyme delivery system for Parkinson's disease.

Batrakova EV, Li S, Reynolds AD, Mosley RL, Bronich TK, Kabanov AV, Gendelman HE.

Bioconjug Chem. 2007 Sep-Oct;18(5):1498-506. Epub 2007 Aug 31.

PMID:
17760417
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.

Zhao Y, Haney MJ, Mahajan V, Reiner BC, Dunaevsky A, Mosley RL, Kabanov AV, Gendelman HE, Batrakova EV.

J Nanomed Nanotechnol. 2011 Sep 10;S4. pii: 003.

PMID:
22288024
[PubMed]
Free PMC Article
7.

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Klyachko NL, Haney MJ, Zhao Y, Manickam DS, Mahajan V, Suresh P, Hingtgen SD, Mosley RL, Gendelman HE, Kabanov AV, Batrakova EV.

Nanomedicine (Lond). 2013 Nov 18. [Epub ahead of print]

PMID:
24237263
[PubMed - as supplied by publisher]
8.

Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease.

Biju K, Zhou Q, Li G, Imam SZ, Roberts JL, Morgan WW, Clark RA, Li S.

Mol Ther. 2010 Aug;18(8):1536-44. doi: 10.1038/mt.2010.107. Epub 2010 Jun 8.

PMID:
20531393
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles.

Chorny M, Hood E, Levy RJ, Muzykantov VR.

J Control Release. 2010 Aug 17;146(1):144-51. doi: 10.1016/j.jconrel.2010.05.003. Epub 2010 May 18.

PMID:
20483366
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases.

Haney MJ, Zhao Y, Harrison EB, Mahajan V, Ahmed S, He Z, Suresh P, Hingtgen SD, Klyachko NL, Mosley RL, Gendelman HE, Kabanov AV, Batrakova EV.

PLoS One. 2013 Apr 19;8(4):e61852. doi: 10.1371/journal.pone.0061852. Print 2013.

PMID:
23620794
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease.

Huh SH, Chung YC, Piao Y, Jin MY, Son HJ, Yoon NS, Hong JY, Pak YK, Kim YS, Hong JK, Hwang O, Jin BK.

J Immunol. 2011 Jul 15;187(2):960-9. doi: 10.4049/jimmunol.1100009. Epub 2011 Jun 17.

PMID:
21685323
[PubMed - indexed for MEDLINE]
Free Article
12.

Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.

Novikova L, Garris BL, Garris DR, Lau YS.

Neuroscience. 2006 Jun 19;140(1):67-76. Epub 2006 Mar 14.

PMID:
16533572
[PubMed - indexed for MEDLINE]
13.

Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease.

Biju KC, Santacruz RA, Chen C, Zhou Q, Yao J, Rohrabaugh SL, Clark RA, Roberts JL, Phillips KA, Imam SZ, Li S.

Neurosci Lett. 2013 Feb 22;535:24-9. doi: 10.1016/j.neulet.2012.12.034. Epub 2013 Jan 4.

PMID:
23295906
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease.

Roy A, Ghosh A, Jana A, Liu X, Brahmachari S, Gendelman HE, Pahan K.

PLoS One. 2012;7(6):e38113. doi: 10.1371/journal.pone.0038113. Epub 2012 Jun 18.

PMID:
22723850
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.

Chung YC, Kim SR, Jin BK.

J Immunol. 2010 Jul 15;185(2):1230-7. doi: 10.4049/jimmunol.1000208. Epub 2010 Jun 21.

PMID:
20566832
[PubMed - indexed for MEDLINE]
Free Article
16.

Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles.

Huang R, Ke W, Han L, Liu Y, Shao K, Ye L, Lou J, Jiang C, Pei Y.

J Cereb Blood Flow Metab. 2009 Dec;29(12):1914-23. doi: 10.1038/jcbfm.2009.104. Epub 2009 Aug 5.

PMID:
19654588
[PubMed - indexed for MEDLINE]
17.

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.

Kanmogne GD, Singh S, Roy U, Liu X, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautam N, Zhou Y, Poluektova L, Kabanov A, Bronich T, Gendelman HE.

Int J Nanomedicine. 2012;7:2373-88. doi: 10.2147/IJN.S29454. Epub 2012 May 8.

PMID:
22661891
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models.

Choi JG, Kim HG, Kim MC, Yang WM, Huh Y, Kim SY, Oh MS.

J Ethnopharmacol. 2011 Mar 24;134(2):414-21. doi: 10.1016/j.jep.2010.12.030. Epub 2010 Dec 30.

PMID:
21195155
[PubMed - indexed for MEDLINE]
19.

Zein-based oral drug delivery system targeting activated macrophages.

Lee S, Alwahab NS, Moazzam ZM.

Int J Pharm. 2013 Sep 15;454(1):388-93. doi: 10.1016/j.ijpharm.2013.07.026. Epub 2013 Jul 19.

PMID:
23876501
[PubMed - indexed for MEDLINE]
20.

Targeted detoxification of selected reactive oxygen species in the vascular endothelium.

Shuvaev VV, Christofidou-Solomidou M, Bhora F, Laude K, Cai H, Dikalov S, Arguiri E, Solomides CC, Albelda SM, Harrison DG, Muzykantov VR.

J Pharmacol Exp Ther. 2009 Nov;331(2):404-11. doi: 10.1124/jpet.109.156877. Epub 2009 Aug 19.

PMID:
19692634
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk